These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14638809)

  • 1. The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate.
    Russo TA; McFadden CD; Carlino-MacDonald UB; Beanan JM; Olson R; Wilding GE
    Infect Immun; 2003 Dec; 71(12):7164-9. PubMed ID: 14638809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection.
    Forsyth VS; Himpsl SD; Smith SN; Sarkissian CA; Mike LA; Stocki JA; Sintsova A; Alteri CJ; Mobley HLT
    mBio; 2020 Apr; 11(2):. PubMed ID: 32345645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection.
    Brumbaugh AR; Smith SN; Mobley HL
    Infect Immun; 2013 Sep; 81(9):3309-16. PubMed ID: 23798537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunization with iron receptor antigens protects against urinary tract infection.
    Alteri CJ; Hagan EC; Sivick KE; Smith SN; Mobley HL
    PLoS Pathog; 2009 Sep; 5(9):e1000586. PubMed ID: 19806177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection.
    Habibi M; Asadi Karam MR; Bouzari S
    Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli.
    Durant L; Metais A; Soulama-Mouze C; Genevard JM; Nassif X; Escaich S
    Infect Immun; 2007 Apr; 75(4):1916-25. PubMed ID: 17145948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against Escherichia coli O157:H7 challenge by immunization of mice with purified Tir proteins.
    Fan HY; Wang L; Luo J; Long BG
    Mol Biol Rep; 2012 Feb; 39(2):989-97. PubMed ID: 21567195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice.
    Wieser A; Romann E; Magistro G; Hoffmann C; Nörenberg D; Weinert K; Schubert S
    Infect Immun; 2010 Aug; 78(8):3432-42. PubMed ID: 20498257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli.
    Russo TA; McFadden CD; Carlino-MacDonald UB; Beanan JM; Barnard TJ; Johnson JR
    Infect Immun; 2002 Dec; 70(12):7156-60. PubMed ID: 12438401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice.
    Lin R; Zhu B; Zhang Y; Bai Y; Zhi F; Long B; Li Y; Wu Y; Wu X; Fan H
    Microb Pathog; 2017 Apr; 105():19-24. PubMed ID: 28163157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections.
    Nesta B; Spraggon G; Alteri C; Moriel DG; Rosini R; Veggi D; Smith S; Bertoldi I; Pastorello I; Ferlenghi I; Fontana MR; Frankel G; Mobley HL; Rappuoli R; Pizza M; Serino L; Soriani M
    mBio; 2012; 3(2):. PubMed ID: 22496310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel vaccine antigen combinations elicit protective immune responses against Escherichia coli sepsis.
    Mellata M; Mitchell NM; Schödel F; Curtiss R; Pier GB
    Vaccine; 2016 Jan; 34(5):656-662. PubMed ID: 26707217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking yersiniabactin import attenuates extraintestinal pathogenic Escherichia coli in cystitis and pyelonephritis and represents a novel target to prevent urinary tract infection.
    Brumbaugh AR; Smith SN; Subashchandrabose S; Himpsl SD; Hazen TH; Rasko DA; Mobley HL
    Infect Immun; 2015 Apr; 83(4):1443-50. PubMed ID: 25624354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First multi-epitope subunit vaccine against extraintestinal pathogenic Escherichia coli delivered by a bacterial type-3 secretion system (T3SS).
    Wieser A; Magistro G; Nörenberg D; Hoffmann C; Schubert S
    Int J Med Microbiol; 2012 Jan; 302(1):10-8. PubMed ID: 22000741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed mucosal-parenteral immunizations with the broadly conserved pathogenic Escherichia coli antigen SslE induce a robust mucosal and systemic immunity without affecting the murine intestinal microbiota.
    Naili I; Vinot J; Baudner BC; Bernalier-Donadille A; Pizza M; Desvaux M; Jubelin G; D'Oro U; Buonsanti C
    Vaccine; 2019 Jan; 37(2):314-324. PubMed ID: 30503655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice.
    Babiuk S; Asper DJ; Rogan D; Mutwiri GK; Potter AA
    Microb Pathog; 2008 Jul; 45(1):7-11. PubMed ID: 18487034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: a novel peptide vaccine candidate.
    Wan CS; Zhou Y; Yu Y; Peng LJ; Zhao W; Zheng XL
    Microbiol Immunol; 2011 Apr; 55(4):247-53. PubMed ID: 21272063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with recombinant protein Ag43::UpaH with alum and 1,25(OH)2D3 adjuvants significantly protects Balb/C mice against urinary tract infection caused by uropathogenic Escherichia coli.
    Habibi M; Azimi S; Khoobbakht D; Roghanian P; Asadi Karam MR
    Int Immunopharmacol; 2021 Jul; 96():107638. PubMed ID: 33848909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal immunization of cocktail/fusion protein containing Tir along with ΔG active fragment of Zot as mucosal adjuvant confers enhanced immunogenicity and reduces E. coli O157:H7 shedding in mice.
    Shekar A; Ramlal S; Jeyabalaji JK; Sripathy MH
    Int Immunopharmacol; 2018 Oct; 63():211-219. PubMed ID: 30103196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
    Langermann S; Möllby R; Burlein JE; Palaszynski SR; Auguste CG; DeFusco A; Strouse R; Schenerman MA; Hultgren SJ; Pinkner JS; Winberg J; Guldevall L; Söderhäll M; Ishikawa K; Normark S; Koenig S
    J Infect Dis; 2000 Feb; 181(2):774-8. PubMed ID: 10669375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.